Andersson released the initial results of the clinical trials. In Sweden, the study used thirty-six patients with forty breast cancer lesions, a Siemens digital mammography system, and a Siemens tomosynthesis module. These forty cancers were very difficult to interpret on the 2D digital mammography system. Results showed that twenty-two out of the forty lesions in the breast cancer sample were better visualized with the 3D tomosynthesis information rather than with the one-view 2D digital mammography system. Eleven cases were still better visualized with tomosynthesis compared with the two-view digital mammography system. Evidence shows that by acquiring several views of the breast at different angels and being able to reconstruct the slice images, tomosynthesis provides better results when compared to conventional and digital mammography. According to Andersson, ”Further studies are in progress, but tomosynthesis will have an important role to play in the future of breast care and is likely to replace mammography in the future.”